Childhood asthma is on the rise and so is obesity. Is there a link between the two? Approximately 17% of US children age 2-9 are obese. These children are increased risk for developing asthma. Childhood asthma accounts for 14 million missed school days a year. Despite the link, a definitive mechanism remains unknown. Although genetic […]
Stepping down asthma treatment is a way to manage patients over time. There can be benefit or harm by stepping down asthma medication. Many factors need to be considered which I will discuss ahead. Asthma is a chronic inflammatory airway disease related to genetic and environmental factors. A stepwise approach by the National Asthma Education […]
Inhaled racepineprhine (RE) became available in September 2012 as a nonprescription treatment for bronchospasm. It is delivered by a handheld electronic nebulizer, its called Asthmanefrin. It is being promoted as a replacement for epinephrine chlorofluoocarbon metered-dose inhaler (Primatene Mist). Results of a study showed that RE was much less effective than albuterol in protecting against […]
Following in the footsteps of Nasocort, the FDA has approved Flonase for OTC use.
Wheezing can affect up to half of all children by age 3.
Asthma prevalence has doubled in the last 30 years.
With the increasing amount of joint replacement surgeries taking place, allergists are seeing patients with metal hypersensitivity.
There has been an ongoing debate over how infant feeding may affect allergic diseases.
Food protein-induced enterolcoitis syndrome (FPIES) is a non IgE-mediated food allergy.
Sublingual Immunotherapy (SLIT) is emerging as an alternative to Subcutaneous Immunotherapy (SCIT).